Pyng Medical Corp (PYT)

Pyng Medical Corp. develops, engineers, and markets trauma and resuscitation products for front-line critical care personnel worldwide. Its product portfolio comprises sternal intraosseous, pelvic stabilization, and tourniquet devices. The company offers FAST1 intraosseous infusion system, which enables the administration of drugs, medications, fluids, and blood to patients that require emergency life-saving treatment; and FASTResponder and FASTCombat sternal intraosseous devices that deliver fluids, medication, and blood easily. It also provides T-PODResponder and T-PODCombat pelvic stabilization devices for the treatment of simple and complex pelvic by binding pelvis to reduce pain, bleeding, and hemorrhage, as well as morbidity and mortality risks; E-MAT and MAT Tourniquet that is applied by the wounded patient or initial responder stops life threatening bleeding to reduce the risk of limb loss and mortality; and MATResponder, which provides first responders with safe compression in controlled increments. In addition, the company offers complete rapid illuminated cricothyrotomy, a life-saving medical product allowing for one-handed surgical airway intervention; and FASTTactical, a sternal intraoseous infusion device. It markets its products to hospital staff, emergency medical services, and military forces. Pyng Medical Corp. is based in Richmond, Canada. Pyng Medical Corp. operates as a subsidiary of Teleflex Incorporated.